The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Clusterin inhibits apoptosis by interacting with activated Bax
Abstract
Clusterin is an enigmatic glycoprotein that is overexpressed in several human cancers such as prostate and breast cancers, and squamous cell carcinoma. Because the suppression of clusterin expression renders human cancer cells sensitive to chemotherapeutic drug-mediated apoptosis, it is currently an antisense target in clinical trials for prostate cancer. However, the molecular mechanisms by which clusterin inhibits apoptosis in human cancer cells are unknown. Here we report that intracellular clusterin inhibits apoptosis by interfering with Bax activation in mitochondria. Intriguingly, in contrast to other inhibitors of Bax, clusterin specifically interacts with conformation-altered Bax in response to chemotherapeutic drugs. This interaction impedes Bax oligomerization, which leads to the release of cytochrome c from mitochondria and caspase activation. Moreover, we also find that clusterin inhibits oncogenic c-Myc-mediated apoptosis by interacting with conformation-altered Bax. Clusterin promotes c-Myc-mediated transformation in vitro and tumour progression in vivo. Taken together, our results suggest that the elevated level of clusterin in human cancers may promote oncogenic transformation and tumour progression by interfering with Bax pro-apoptotic activities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CLU gene encodes clusterin or APOJ that besides its functions in lipid transport, membrane recycling, cell adhesion, and apoptosis (90, 444, 600, 677) affects transvascular A 𝛃 clearance by promoting A 𝛃 42 efflux across the BBB (580).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [677]
Citations
Cites
1 retracted
Ku70 suppresses the apoptotic translocation of Bax to mitochondria
Sawada, M., Sun, W., Hayes, P. L., Leskov, K., Boothman, D. A., & Matsuyama, S. (2003) · Nature Cell Biology · doi:10.1038/ncb950 · Cited by 353
RetractedCleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis
Li, H., Zhu, H., Xu, C.-J., & Yuan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81590-1 · Cited by 4,445
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
Wei, M. C., Zong, W.-X., Cheng, E. H.-Y., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., & Korsmeyer, S. J. (2001) · Science · doi:10.1126/science.1059108 · Cited by 3,988
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Vaux, D., Cory, S., & Adams, J. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,355
(2001) · PubMed · Cited by 2,381
Cheng, E. H. Y., Wei, M. C., Weiler, S., Flavell, R. A., Mak, T. W., Lindsten, T., & Korsmeyer, S. J. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00320-3 · Cited by 1,735
Bid, Bax, and Lipids Cooperate to Form Supramolecular Openings in the Outer Mitochondrial Membrane
Kuwana, T., Mackey, M. R., Perkins, G. A., Ellisman, M. H., Latterich, M., Schneiter, R., Green, D. R., & Newmeyer, D. D. (2002) · Cell · doi:10.1016/s0092-8674(02)01036-x · Cited by 1,513
Wang, S., Gao, J., Lei, Q., Rozengurt, N., Pritchard, C., Jiao, J., Thomas, G. V., Li, G., Roy-Burman, P., Nelson, P. S., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00215-0 · Cited by 1,109
Apoptotic cell death induced by c-myc is inhibited by bcl-2
Bissonnette, R. P., Echeverri, F., Mahboubi, A., & Green, D. R. (1992) · Nature · doi:10.1038/359552a0 · Cited by 957
Zong, W., Lindsten, T., Ross, A. J., MacGregor, G. R., & Thompson, C. B. (2001) · Genes & Development · doi:10.1101/gad.897601 · Cited by 809
Cited by
Sorted by citations
Items 101–200 of 451
Kim, N., Yoo, J. C., Han, J. Y., Hwang, E. M., Kim, Y. S., Jeong, E. Y., Sun, C., Yi, G., Roh, G. S., Kim, H. J., et al. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22836 · Cited by 60
Clusterin facilitates metastasis by EIF3I/Akt/MMP13 signaling in hepatocellular carcinoma
Wang, C., Jin, G., Jin, H., Wang, N., Luo, Q., Zhang, Y., Gao, D., Jiang, K., Gu, D., Shen, Q., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.3093 · Cited by 59
Self-citationChapter 9 Oxidative Stress in Malignant Progression
Trougakos, I. P., & Gonos, E. S. (2009) · Advances in cancer research · doi:10.1016/s0065-230x(09)04009-3 · Cited by 60
Xiu, P., Dong, X., Dong, X., Xu, Z., Zhu, H., Liu, F., Wei, Z., Zhai, B., Kanwar, J. R., Jiang, H., et al. (2012) · Cancer Science · doi:10.1111/cas.12088 · Cited by 59
Self-citationJo, H., Jia, Y., Subramanian, K. K., Hattori, H., & Luo, H. R. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01240-07 · Cited by 61
Clusterin is epigenetically regulated in prostate cancer
Rauhala, H. E., Porkka, K. P., Saramäki, O. R., Tammela, T. L. J., & Visakorpi, T. (2008) · International Journal of Cancer · doi:10.1002/ijc.23658 · Cited by 57
Brain clusterin protein isoforms and mitochondrial localization
Herring, S. K., Moon, H.-J., Rawal, P., Chhibber, A., & Zhao, L. (2019) · eLife · doi:10.7554/elife.48255 · Cited by 59
Cohen, A., Wang, E., Chisholm, K. A., Kostyleva, R., O'Connor‐McCourt, M. D., & Pinto, D. M. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.11.004 · Cited by 56
Induction of Clusterin by AKT—Role in Cytoprotection against Docetaxel in Prostate Tumor Cells
Zhong, B., Sallman, D. A., Gilvary, D. L., Pernazza, D., Sahakian, E., Fritz, D., Cheng, J. Q., Trougakos, I. P., Sheng, W., & Djeu, J. Y. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0880 · Cited by 56
Chi, K. N., Zoubeidi, A., & Gleave, M. E. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780802528609 · Cited by 56
SMOC1 is a tenascin-C interacting protein over-expressed in brain tumors
Brellier, F., Ruggiero, S., Zwolanek, D., Martina, E., Heß, D., Brown-Luedi, M., Hartmann, U., Koch, M., Merlo, A., Lino, M. M., et al. (2011) · Matrix Biology · doi:10.1016/j.matbio.2011.02.001 · Cited by 58
Clusterin mediates TRAIL resistance in prostate tumor cells
Sallman, D. A., Chen, X., Zhong, B., Gilvary, D. L., Zhou, J., Wei, S., & Djeu, J. Y. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0345 · Cited by 55
Targeting the Apoptosis Pathway in Prostate Cancer
Zielinski, R., Eigl, B. J., & Chi, K. N. (2013) · The Cancer Journal · doi:10.1097/ppo.0b013e3182801cf7 · Cited by 54
Increased Clusterin Expression in Fuchs’ Endothelial Dystrophy
Jurkunas, U. V., Bitar, M. S., Rawe, I., Harris, D. L., Colby, K. A., & Joyce, N. C. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1405 · Cited by 54
Differential Expression of Serum Clusterin Isoforms in Colorectal Cancer
Rodríguez-Piñeiro, A. M., de la Cadena, M. P., López-Saco, Á., & Rodrı́guez-Berrocal, F. J. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600143-mcp200 · Cited by 53
Mass spectrometry analysis of plasma from amyotrophic lateral sclerosis and control subjects
Xu, Z., Lee, A., Nouwens, A. S., Henderson, R. D., & McCombe, P. (2018) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2018.1433689 · Cited by 55
Self-citationHMGB1 induction of clusterin creates a chemoresistant niche in human prostate tumor cells
Zhou, J., Chen, X., Gilvary, D. L., Tejera, M. M., Eksioglu, E. A., Wei, S., & Djeu, J. Y. (2015) · Scientific Reports · doi:10.1038/srep15085 · Cited by 51
Identification of VDR-Responsive Gene Signatures in Breast Cancer Cells
Towsend, K., Treviño, V., Falciani, F., Stewart, P. M., Hewison, M., & Campbell, M. J. (2006) · Oncology · doi:10.1159/000100989 · Cited by 50
Clusterin as modulator of carcinogenesis: A potential avenue for targeted cancer therapy
Praharaj, P. P., Patra, S., Panigrahi, D. P., Patra, S. K., & Bhutia, S. K. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188500 · Cited by 49
Prochnow, H., Gollan, R., Rohne, P., Hassemer, M., Koch-Brandt, C., & Baiersdörfer, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075303 · Cited by 52
Rizzi, F., Caccamo, A. E., Belloni, L., & Bettuzzi, S. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21671 · Cited by 49
Exposure to 6PPD-Q induces dysfunctions of ovarian granulosa cells: Its potential role in PCOS
Yu, H., Zhang, W., Wang, D., Shi, B., Zhu, Y., He, J., He, J., Hong, J., Xu, X., Zheng, X., et al. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.137037 · Cited by 48
Apoptosis in Carcinogenesis and Chemotherapy
Chen, G. G., & Lai, P. B. S. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9597-9 · Cited by 49
The role of Clusterin in cancer metastasis
Peng, M., Deng, J., Zhou, S., Tao, T., Su, Q., Yang, X., & Yang, X. (2019) · Cancer Management and Research · doi:10.2147/cmar.s196273 · Cited by 48
Bi, J., Guo, A., Lai, R., Li, B., Zhong, J. F., Wu, H., Xie, Z., He, L., Lv, L., Lau, S., et al. (2010) · Neoplasma · doi:10.4149/neo_2010_03_191 · Cited by 47
Pucci, S., Mazzarelli, P., Sesti, F., Boothman, D. A., & Spagnoli, L. G. (2009) · Cell Cycle · doi:10.4161/cc.8.3.7652 · Cited by 46
Genetic inactivation of ApoJ/clusterin: effects on prostate tumourigenesis and metastatic spread
Bettuzzi, S., Davalli, P., Davoli, S., Chayka, O., Rizzi, F., Belloni, L., Pellacani, D., Fregni, G., Astancolle, S., Fassan, M., et al. (2009) · Oncogene · doi:10.1038/onc.2009.286 · Cited by 46
Shimizu, T., Choi, E.-Y. K., Petersen, C. P., Noto, J. M., Romero–Gallo, J., Piazuelo, M. B., Washington, M. K., Peek, R. M., & Goldenring, J. R. (2016) · The Journal of Pathology · doi:10.1002/path.4735 · Cited by 46
Magadoux, L., Isambert, N., Plenchette, S., Jeannin, J., & Laurens, V. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2517 · Cited by 45
Glycobiology in the cytosol: The bitter side of a sweet world
Funakoshi, Y., & Suzuki, T. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.09.009 · Cited by 45
Suspension state promotes metastasis of breast cancer cells by up-regulating cyclooxygenase-2
Zhang, X., Li, Y., Chien, S., & Lv, Y. (2018) · Theranostics · doi:10.7150/thno.25434 · Cited by 45
Liu, T., Liu, P. Y., Tee, A. E., Haber, M., Norris, M. D., Gleave, M. E., & Marshall, G. M. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.03.002 · Cited by 43
Jemmerson, R., Staskus, K., Higgins, L., Conklin, K. F., & Kelekar, A. (2021) · APOPTOSIS · doi:10.1007/s10495-020-01647-9 · Cited by 43
Alsherbiny, M. A., Bhuyan, D. J., Radwan, I., Chang, D., & Li, C. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157840 · Cited by 43
Mishima, K., Inoue, H., Nishiyama, T., Mabuchi, Y., Amano, Y., Ide, F., Matsui, M., Yamada, H., Yamamoto, G., Tanaka, J., et al. (2012) · Stem Cells · doi:10.1002/stem.1173 · Cited by 42
Heat shock proteins in prostate cancer: from tumorigenesis to the clinic
Ciocca, D. R., Fanelli, M. A., Cuello-Carrión, F. D., & Castro, G. N. (2010) · International Journal of Hyperthermia · doi:10.3109/02656731003776968 · Cited by 42
Tang, Y. M., Liu, F., Zheng, C., Sun, S., & Jiang, Y. (2012) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-31-73 · Cited by 42
Goetz, E. M., Shankar, B. S., Zou, Y. S., Morales, J. C., Luo, X., Araki, S., Bachoo, R. M., Mayo, L. D., & Boothman, D. A. (2011) · Oncogene · doi:10.1038/onc.2011.92 · Cited by 42
Gleave, M. E., & CHI, K. N. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1359.001 · Cited by 42
Sahin, M. A., Şahın, E., Gümüşlü, S., Erdoğan, A., & Gültekin, M. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9253-0 · Cited by 43
Roy, L., LaBoissière, S., Abdou, E., Thibault, G., Hamel, N., Taheri, M., Boismenu, D., Lanoix, J., Kearney, R. E., & Paiement, J. M. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.05.008 · Cited by 42
Identification of Clusterin Domain Involved in NF-κB Pathway Regulation
Essabbani, A., Margottin-Goguet, F., & Chiocchia, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.c109.057133 · Cited by 42
Salehi, M., Akbari, H., Heidari, M. H., Molouki, A., Murulitharan, K., Moeini, H., Novin, M. G., Abed, F., Taheri, H., Fadaei, F., et al. (2013) · Molecular Reproduction and Development · doi:10.1002/mrd.22202 · Cited by 41
Cheriyath, V., Kuhns, M. A., Kalaycio, M. E., & Borden, E. C. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.42 · Cited by 42
Leskov, K., Araki, S., Lavik, J., Gómez, J. A., Gama, V., Gonos, E. S., Trougakos, I. P., Matsuyama, S., & Boothman, D. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.252957 · Cited by 41
Naik, P. P., Mukhopadhyay, S., Praharaj, P. P., Bhol, C. S., Panigrahi, D. P., Mahapatra, K. K., Patra, S., Saha, S., Panda, A. K., Panda, K., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118722 · Cited by 41
Kususda, Y., Miyake, H., Gleave, M. E., & Fujisawa, M. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.209 · Cited by 41
Clusterin expression can be modulated by changes in TCF1-mediated Wnt signaling
Schepeler, T., Mansilla, F., Christensen, L. L., Orntoft, T. F., & Andersen, C. L. (2007) · Journal of Molecular Signaling · doi:10.1186/1750-2187-2-6 · Cited by 41
High Clusterin Expression Correlates with a Poor Outcome in Stage II Colorectal Cancers
Kevans, D., Foley, J., Tenniswood, M., Sheahan, K. D., Hyland, J. M., O’Donoghue, D. P., Mulcahy, H. E., & O'Sullivan, J. N. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0302 · Cited by 41
Tang, X., Liang, Y., Sun, G., He, Q., Hou, Z., Jiang, X., Gao, P., & Qu, H. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05299-2 · Cited by 40
Redondo, M., Téllez, T., Roldan, M. J., Serrano, A., García‐Aranda, M., Gleave, M. E., Hortas, M. L., & Morell, M. (2007) · Breast Cancer Research · doi:10.1186/bcr1835 · Cited by 40
Wu, J., Qin, H., Li, T., Cheng, K., Dong, J., Tian, M., Chai, N., Guo, H., Li, J., You, X. Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8287 · Cited by 39
Lee, J., Hong, S., Kwon, H., Park, S. E., Rhee, E., Park, C., Oh, K.-W., Park, S., & Lee, W. (2019) · Cell Stress and Chaperones · doi:10.1007/s12192-019-01012-z · Cited by 39
Discovery of gastric cancer specific biomarkers by the application of serum proteomics
Yoo, M., Park, J., Han, H. S., Yun, Y., Kang, J. W., Choi, D., Lee, J. W., Jung, J. H., Lee, K., & Kim, K. P. (2017) · PROTEOMICS · doi:10.1002/pmic.201600332 · Cited by 39
Deb, M., Sengupta, D., Rath, S. K., Kar, S., Parbin, S., Shilpi, A., Pradhan, N., Bhutia, S. K., Roy, S., & Patra, S. K. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.04.021 · Cited by 38
Serum and Tissue Profiling in Bladder Cancer Combining Protein and Tissue Arrays
Orenes‐Piñero, E., Barderas, R., Rico, D., Casal, J. I., Pisano, D. G., Navajo, J. A., Ferran Algaba, B., Piulats, J. M., & Sänchez‐Carbayo, M. (2009) · Journal of Proteome Research · doi:10.1021/pr900273u · Cited by 38
Clusterin Seals the Ocular Surface Barrier in Mouse Dry Eye
Bauskar, A., Mack, W. J., Mauris, J., Argüeso, P., Heur, M., Nagel, B., Kolar, G. R., Gleave, M. E., Nakamura, T., Kinoshita, S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138958 · Cited by 38
Zhou, J., Donatelli, S. S., Gilvary, D. L., Tejera, M. M., Eksioglu, E. A., Chen, X., Coppola, D., Sheng, W., & Djeu, J. Y. (2016) · Scientific Reports · doi:10.1038/srep29521 · Cited by 38
Divergent roles for Clusterin in Lung Injury and Repair
Habiel, D., Camelo, A., Espíndola, M., Burwell, T., Hanna, R., Miranda, E., Carruthers, A., Bell, M., Coelho, A., Liu, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15670-5 · Cited by 36
Ciocan, C. A., Jurj, A. M., Zănoagă, O., Cojocneanu, R., Pop, L., Moldovan, A. I., Moldovan, C. S., Zimța, A., Ráduly, L., Bica, C., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01736-2 · Cited by 38
Antonelou, M. H., Kriebardis, A. G., Stamoulis, K. E., Trougakos, I. P., & Papassideri, I. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026032 · Cited by 38
Kliger, Y., Levy, O., Oren, A., Ashkenazy, H., Tiran, Z., Novik, A., Rosenberg, A. Z., Iosub‐Amir, A., Wool, A., Toporik, A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906514106 · Cited by 37
Praharaj, P. P., Patra, S., Singh, A., Panigrahi, D. P., Lee, H. Y., Kabir, M. F., Hossain, M. K., Patra, S. K., Patro, B. S., Patil, S., et al. (2024) · Autophagy · doi:10.1080/15548627.2024.2309904 · Cited by 36
Determinants of eosinophil survival and apoptotic cell death
Shen, Z.-J., & Malter, J. S. (2015) · APOPTOSIS · doi:10.1007/s10495-014-1072-2 · Cited by 36
The APP intracellular domain (AICD) potentiates ER stress-induced apoptosis
Kögel, D., Concannon, C. G., Müller, T., König, H., Bonner, C., Poeschel, S., Chang, S., Egensperger, R., & Prehn, J. H. M. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.06.012 · Cited by 38
Montiel, M., Urso, L., de la Blanca, E. P., Marsigliante, S., & nez, E. J. E. (2009) · Cellular Physiology and Biochemistry · doi:10.1159/000218191 · Cited by 36
Redondo, M., Rodrigo, I., Alcaide, J., Téllez, T., Roldan, M. J., Fúnez, R., Díaz-Martín, A. A., Rueda, A., & Jiménez, E. G. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03565.x · Cited by 35
Ascorbate induces apoptosis in melanoma cells by suppressing Clusterin expression
Mustafi, S., Sant, D., Liu, Z., & Wang, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-03893-5 · Cited by 37
Assadsangabi, A., Evans, C. A., Corfe, B. M., & Lobo, A. (2019) · Gastroenterology Research and Practice · doi:10.1155/2019/1426954 · Cited by 35
Xie, Y., Li, Y., Chen, J., Ding, H., & Zhang, X. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1162662 · Cited by 36
Luo, X., Suzuki, M., Ghandhi, S. A., Amundson, S. A., & Boothman, D. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099983 · Cited by 35
Nogai, H., Rosowski, M., Grün, J. R., Rietz, A., Debus, N., Schmidt, G., Lauster, C., Janitz, M., Vortkamp, A., & Lauster, R. (2007) · Differentiation · doi:10.1111/j.1432-0436.2007.00223.x · Cited by 34
Tunçdemi̇r, M., & Öztürk, M. (2008) · Journal of Molecular Histology · doi:10.1007/s10735-008-9201-2 · Cited by 34
Anti-apoptotic effect of clusterin on cisplatin-induced cell death of retinoblastoma cells
Song, H. B., Jun, H.-O., Kim, J. H., Yu, Y. S., Kim, K.-W., Min, B.-H., & Kim, J. H. (2013) · Oncology Reports · doi:10.3892/or.2013.2764 · Cited by 33
Self-citationLiu, G., Zhang, H., Hao, F., Hao, J., Pan, L., Zhao, Q. C., & Wo, J. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000487295 · Cited by 35
Self-citationClusterin overexpression and relapse-free survival in breast cancer.
Yom, C. K., Woo, H., Min, S. Y., Kang, S. Y., & Kim, H. S. (2009) · PubMed · Cited by 33
Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis
Nakouzi, N. A., Wang, C. K., Beraldi, E., Jäger, W., Ettinger, S., Fazli, L., Nappi, L., Bishop, J. L., Zhang, F., Chauchereau, A., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201506059 · Cited by 33
Self-citationClusterin inhibition mediates sensitivity to chemotherapy and radiotherapy in human cancer
García‐Aranda, M., Téllez, T., Muñoz, M., & Redondo, M. (2017) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000507 · Cited by 33
Li, K., Sun, J., Yang, J., Roberts, S. M., Zhang, X., Cui, X., Wei, S., & Ma, L. Q. (2017) · Environmental Science & Technology · doi:10.1021/acs.est.7b02690 · Cited by 33
Clusterin drives myeloid bias in aged hematopoietic stem cells by regulating mitochondrial function
Sun, N., Lin, C.-H., Li, M. Y., Wang, Y., Chen, D., Ren, X., Zhang, F., & Zhang, Y. (2025) · Nature Aging · doi:10.1038/s43587-025-00908-z · Cited by 32
Novel therapeutics for the management of castration‐resistant prostate cancer (CRPC)
Lee, D. J., Cha, E. K., Dubin, J. M., Beltran, H., Chromecki, T. F., Fajković, H., Scherr, D. S., Tagawa, S. T., & Shariat, S. F. (2011) · British Journal of Urology · doi:10.1111/j.1464-410x.2011.10643.x · Cited by 32
Diverse functions of clusterin promote and protect against the development of pulmonary fibrosis
Peix, L., Evans, I., Pearce, D. R., Simpson, J. K., Maher, T. M., & McAnulty, R. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-20316-1 · Cited by 32
Tian, Y., Xiao, Y., Geng, T., Sun, C., Gu, J., Tang, K., Liu, B., Liu, Y., & Fa, S. (2020) · Biology of the Cell · doi:10.1111/boc.202000030 · Cited by 32
Essential role of clusterin in pancreas regeneration
Lee, S., Hong, S., Min, B., Shim, Y.-J., Lee, K., Lee, I., Bendayan, M., Aronow, B. J., & Park, I.-S. (2011) · Developmental Dynamics · doi:10.1002/dvdy.22556 · Cited by 33
Castino, R., Peracchio, C., Salini, A., Nicotra, G., Trincheri, N. F., Démoz, M., Valente, G., & Isidoro, C. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00435.x · Cited by 31
Phospholipase A2-activating protein (PLAA) enhances cisplatin-induced apoptosis in HeLa cells
Zhang, F., Suárez, G., Sha, J., Sierra, J. C., Peterson, J. W., & Chopra, A. K. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.02.018 · Cited by 31
Fleck, D., Phu, L., Verschueren, E., Hinkle, T. B., Reichelt, M., Bhangale, T., Haley, B., Wang, Y., Graham, R., Kirkpatrick, D. S., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0116-19.2019 · Cited by 31
Review: Castration-resistant prostate cancer: new science and therapeutic prospects
Joaquim Bellmunt, B., & Oh, W. K. (2010) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834009359769 · Cited by 31
Ghantasala, S., Pai, M. G. J., Biswas, D., Gahoi, N., Mukherjee, S., Manubhai, K. P., Nissa, M. U., Srivastava, A., Epari, S., Shetty, P. M., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.548243 · Cited by 30
DeubiKuitylation: A novel DUB enzymatic activity for the DNA repair protein, Ku70
RATHAUS, M., Lerrer, B., & Cohen, H. Y. (2009) · Cell Cycle · doi:10.4161/cc.8.12.8864 · Cited by 33
Proapoptotic role of nuclear clusterin in brain
Kim, N., & Choi, W. S. (2011) · Anatomy & Cell Biology · doi:10.5115/acb.2011.44.3.169 · Cited by 29
Clusterin and FOXL2 Act Concordantly to Regulate Pituitary Gonadotroph Adenoma Growth
Chesnokova, V., Zonis, S., Wawrowsky, K., Tani, Y., Ben-Shlomo, A., Ljubimov, V. A., Mamelak, A. N., Bannykh, S., & Melmed, S. K. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1158 · Cited by 30
Binding of Human Proteins to Amyloid-β Protofibrils
Rahman, M. M., Zetterberg, H., Lendel, C., & Härd, T. (2014) · ACS Chemical Biology · doi:10.1021/cb5008663 · Cited by 31
NBPF is a potential DNA-binding transcription factor that is directly regulated by NF-κB
Zhou, F., Xing, Y., Xu, X., Yang, Y., Zhang, J., Ma, Z., & Wang, J. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.07.022 · Cited by 29
Clusterin confers gmcitabine resistance in pancreatic cancer
Chen, Q., Wang, Z., Zhang, K., Liu, X., Cao, W., Zhang, L., Zhang, S., Yan, B., Wang, Y., & Xia, C. (2011) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-9-59 · Cited by 29
Panes-Fernández, J., Nguyen, T. K. O., Gao, H., Christensen, T. A., Stojakovic, A., Trushin, S., Salisbury, J. L., Fuentealba, J., & Trushina, E. V. (2023) · Cells · doi:10.3390/cells12081111 · Cited by 28
Hu, W., Xie, N., Pan, M., Zhang, Q., Zhang, H., Wang, F., & Qu, F. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117025 · Cited by 28
Self-citationXiong, J., Wang, S., Chen, T., Shu, X., Mo, X., Chang, G., Chen, J., Li, C., Luo, H., & Lee, J. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.29135 · Cited by 28
Equine seminal plasma and sperm membrane: Functional proteomic assessment
Guasti, P. N., de Souza, F. F., Scott, C., Papa, P. M., de Camargo, L. S., Schmith, R. A., Monteiro, G. A., Hartwig, F. P., & Papa, F. (2020) · Theriogenology · doi:10.1016/j.theriogenology.2020.06.014 · Cited by 28
The expression of FLNA and CLU in PBMCs as a novel screening marker for hepatocellular carcinoma
Patarat, R., Riku, S., Kunadirek, P., Chuaypen, N., Tangkijvanich, P., Mutirangura, A., & Puttipanyalears, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-94330-1 · Cited by 28
Metadata
- Authors
- Zhang, H., Kim, J. K., Edwards, C. A., Xu, Z., Taichman, R., & Wang, C.-Y.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Wang, Cun-Yu
- Venue
- Nature Cell Biology
- Published
- 2005-08-21
- Volume
- 7
- Issue
- 9
- Pages
- 909-915
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2093107372
- Cited by
- 453
- References
- 27
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 13 · 2023: 18 · 2022: 19 · 2021: 22 · 2020: 21 · 2019: 16 · 2018: 19 · 2017: 16 · 2016: 18 · 2015: 20 · 2014: 24 · 2013: 27 · 2012: 31
- FWCI
- 10.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Army Research Office
- Topics
- Health Sciences › Medicine › Oncology › Clusterin in disease pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Keywords
- clusterin, apoptosis inhibition, Bax activation, Bax oligomerization, cytochrome c release, caspase activation, c-Myc, oncogenic transformation, tumor progression, chemosensitization, prostate cancer, breast cancer, squamous cell carcinoma, mitochondrial apoptosis
- MeSH terms
- Animals, Antineoplastic Agents, Cell Transformation, Neoplastic, Glycoproteins, Humans, Mitochondria, Neoplasms, Protein Conformation, Proto-Oncogene Proteins c-myc, Apoptosis, Molecular Chaperones, Drug Resistance, Neoplasm, Proto-Oncogene Proteins c-bcl-2, Caspases, Cytochromes c, Cell Line, Tumor, bcl-2-Associated X Protein, Clusterin, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review